Scrip’s Five Must-Know Things – 13 November 2023

Citeline Podcasts
13/11/2023 16 min
Scrip’s Five Must-Know Things – 13 November 2023

Listen "Scrip’s Five Must-Know Things – 13 November 2023"

Descargar episodio Ver en sitio original

Episode Synopsis

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US approval for Lilly’s obesity drug; a look at the future of the obesity market; BMS’s ADC deal; Roche’s MS plans; and one Chinese firm’s CAR-T plans.
https://scrip.citeline.com/SC149349/Quick-Listen-Scrips-Five-MustKnow-Things

More episodes of the podcast Citeline Podcasts

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 10/11/2025
Scrip's Five Must-Know Things - Nov. 10, 2025 10/11/2025
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center 07/11/2025
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology 06/11/2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 04/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025 04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform 31/10/2025
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine 31/10/2025
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space? 31/10/2025
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast) 31/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA